Advent Financial Initiates a Positive Coverage on Nouveau Life Pharmaceuticals, Inc. (PINKSHEETS: HRID)
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 03/13/12 -- Advent Financial is pleased to announce that it has initiated positive research coverage on Nouveau Life Pharmaceuticals, Inc. (PINKSHEETS: HRID).
To view the report in its entirety, please visit: under recent reports.
About Nouveau Life Pharmaceuticals, Inc.:
Nouveau Life's mission is to be the leading provider of safe and healthy nutraceutical solutions for those suffering with common medical conditions. The Company's initial products have been developed to provide the millions of people suffering with sexual dysfunction with a solution comprised of all-natural ingredients. Plans are now underway to expand the nutraceutical portfolio to launch all-natural supplements for weight loss, acne and high cholesterol. The Company introduced Azúl Instant™ back in January, an all-natural supplement for ED that provides the millions of men suffering from the condition with a safe alternative to prescription drugs. Developed by a team of experts, the Company's goal is to create the healthiest and most effective all-natural male enhancer ever formulated. Unlike pharmaceutical drugs such as Cialis, Viagra and Levitra, Azúl Instant™ carries no dangerous side effects.
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
Nouveau Life Pharmaceuticals, Inc.
954-903-2993
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.03.2012 - 08:33 Uhr
Sprache: Deutsch
News-ID 1092292
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
NEW YORK, NY
Phone:
Kategorie:
Drugs
Anmerkungen:
Diese Pressemitteilung wurde bisher 81 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Advent Financial Initiates a Positive Coverage on Nouveau Life Pharmaceuticals, Inc. (PINKSHEETS: HRID)
"
steht unter der journalistisch-redaktionellen Verantwortung von
Advent Financial, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
